Bright light therapy for melanoma or lung cancer patients starting immunotherapy
Part of Cancer, Lungs & breathing, Skin clinical trials.
This study tests if daily bright light therapy can help people with advanced melanoma or lung cancer feel better during their first immunotherapy treatment. The light box is used at home for a short time each morning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced melanoma or non-small cell lung cancer that can't be removed with surgery.
- You are about to start your first immunotherapy treatment (like Keytruda or a combination).
- You are 18 or older and can use the internet at home.
- You are not using melatonin or prescription sleep aids, and do not have certain eye conditions.
- You do not have bipolar disorder, recent psychosis, or poorly controlled seizures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a simple blood test can predict how well your immune system will respond to immunotherapy (such as Keytruda or Opdivo). You may qualify if you have lung cancer (NSCLC) or advanced melanoma and are about to start this type of treatment for the first time.
This study looks at whether using a special kind of everyday light (called ambient light) can help people with multiple myeloma as they prepare for their first stem cell transplant. It may be aiming to improve comfort or recovery by affecting sleep and the body’s natural signals from light.
This early trial tests CBL0137 along with ipilimumab and nivolumab (two immune-based cancer medicines) in people with stage III or possibly stage IV melanoma that can be biopsied. It may help shrink melanoma and improve immune control, while also learning how safe and effective this combination is.
This study tests whether special light therapy timed to your body's natural rhythms can improve how well your immune cells (called TIL therapy) fight advanced melanoma. You must already be enrolled in standard TIL therapy and have progressed despite previous immunotherapy.
This study tests whether giving immunotherapy (medicines that help your immune system fight cancer) at specific times of day—aligned with your body's natural rhythms—works better for advanced melanoma. Researchers will randomly assign you to receive treatment either on a timed schedule or a standard schedule.
This trial tests whether a structured bright-light exposure routine combined with a specific exercise program can help people with newly diagnosed lung or esophageal cancer. You may be eligible if you’re in early-to-middle cancer stages and able to safely participate in walking-based activities.
Hear when a new Melanoma (Skin Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.